Cargando…
Apixaban-Induced Hepatotoxicity
Apixaban is widely used to prevent and manage thromboembolic disease. Due to it being fairly new in the market, we are still understanding its complete risk profile. We present a case of a 61-year-old female with no prior history of liver disease, who developed severe transaminitis shortly after the...
Autores principales: | Ansari, Umair, Asghar, Zahra, Oswald, Meghan, Ng, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985735/ https://www.ncbi.nlm.nih.gov/pubmed/35402115 http://dx.doi.org/10.7759/cureus.23879 |
Ejemplares similares
-
Apixaban-Induced Pseudo-Ludwig’s Angina
por: Figaro, Nicholas, et al.
Publicado: (2022) -
Venous Thromboembolism While on Anticoagulation With Apixaban
por: Mazahreh, Farah, et al.
Publicado: (2021) -
Delayed Vesicular Urticarial Dermatosis Due to Apixaban
por: Garzon-Siatoya, Wendy T, et al.
Publicado: (2021) -
Clinically Ambiguous Hemorrhagic Cardiac Tamponade Associated with Apixaban
por: Aguilar-Gallardo, Jose S, et al.
Publicado: (2022) -
Adrenal Hemorrhage in a Patient Anticoagulated with Apixaban with Antiphospholipid Syndrome
por: Sanford, Zachary, et al.
Publicado: (2019)